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Introduction
Accurate segregation of replicated chromosomes during mitosis 
is essential for the maintenance of genomic integrity. To ensure 
faithful chromosome segregation, eukaryotic cells have devel-
oped a surveillance network called the mitotic checkpoint that 
delays anaphase onset until sister kinetochores of duplicated 
chromosomes are properly attached to microtubules emanating 
from opposite spindle poles (for reviews see Kops et al., 2004; 
Musacchio and Salmon, 2007). Early in mitosis, various mitotic 
checkpoint proteins, including Bub1, Bub3, BubR1, Mad1, 
Mad2, and Mps1, are recruited to unattached kinetochores. 
These kinetochore-associated checkpoint proteins promote the 
formation of diffusible Mad2, BubR1, Bub3, and Cdc20 protein 
complexes that inhibit the anaphase-promoting complex/cyclo-
some (APC/C), an E3 ubiquitin ligase that drives cells into ana-
phase by targeting securin and cyclin B for destruction by the 
26S proteasome (for reviews see Kops et al., 2005; Peters, 2006; 
Musacchio and Salmon, 2007). After all chromosome pairs are 
properly attached to the spindle and aligned in the metaphase 
plate, mitotic checkpoint proteins dissociate from the APC/C, 
thus triggering the ubiquitin-mediated destruction of securin and 
cyclin B. Separase, a protease that is inhibited by securin binding 
and cyclin B/Cdk1-mediated phosphorylation, then cleaves the 
kleisin subunit Scc1 of cohesin, thereby allowing sister chroma-
tid disjunction and anaphase onset (for reviews see Nasmyth 
and Haering, 2005; Peters, 2006).
The discovery of the mitotic checkpoint led to speculation 
that mutations in mitotic checkpoint genes might play a role 
in the development of aneuploidy in human cancers (Jallepalli 
and Lengauer, 2001; Draviam et al., 2004). Over recent years, 
  mutant mitotic checkpoint genes have indeed been identifi  ed in 
various human cancers, although at relatively low frequency 
(Weaver and Cleveland, 2006; for reviews see Kops et al., 2005; 
Yuen et al., 2005). The Bub1 kinase is mutated in several cancer 
types, including colorectal, lung and thyroid cancer, and T cell 
leukemia (Cahill et al., 1998; Ohshima et al., 2000; Ru et al., 
2002; Shichiri et al., 2002). In addition, Bub1 expression is fre-
quently reduced in several human cancers, including colorectal, 
gastric, and esophageal cancers (Shigeishi et al., 2001; Shichiri 
et al., 2002; Doak et al., 2004).
Bub1 is a serine/threonine protein kinase that targets to un-
attached kinetochores at the onset of mitosis (Roberts et al., 1994; 
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Taylor and McKeon, 1997; Yu and Tang, 2005). There it is 
thought to phosphorylate Cdc20, thereby preventing Cdc20 
from activating the APC/C (Chung and Chen, 2003; Chen, 
2004; Tang et al., 2004a). Additionally, Bub1 is required for 
Mad1–Mad2 localization to unattached kinetochores. These 
complexes function to prevent premature APC/C activation by 
changing the conformation of monomeric Mad2 such that it 
can effi  ciently bind to and inhibit the APC/C coactivator Cdc20 
(Luo et al., 2002, 2004; Sironi et al., 2002). Besides Mad1 and 
Mad2, Bub1 also recruits BubR1, Bub3, centromere protein E 
(CENP-E), and CENP-F to unattached kinetochores (Sharp-
Baker and Chen, 2001; Johnson et al., 2004). Several of these 
proteins are important for microtubule-kinetochore attach-
ment, which may explain why Bub1-depleted cells have chromo-
some congression defects (Meraldi and Sorger, 2005). In addition, 
Bub1 contributes to the stability and inner centromere localiza-
tion of Shugoshin (Sgo1), a protein that functions as an adaptor 
for phosphatase PP2A (Tang et al., 2004b, 2006; Kitajima et al., 
2005). At the inner centromere, PP2A counteracts the Plk1-
mediated release of cohesin until anaphase onset, thus pre-
venting the premature separation of sister centromeres (Riedel 
et al., 2006). Bub1 also controls the stability and correct posi-
tioning of the chromosomal passenger complex to the inner 
centromeric region of sister chromosomes, a function that 
appears to be critical for the recruitment of Sgo1 to centro-
meres (Boyarchuk et al., 2007).
Although the molecular mechanisms of Bub1 action are 
beginning to emerge, the physiological role of Bub1 in higher 
eukaryotes is still unknown. The most defi  nitive way to address 
this role would be to generate Bub1 knockout mice by homolo-
gous recombination in embryonic stem (ES) cells. However, 
previous gene knockout studies for Mad1, Mad2, BubR1, and 
Bub3 revealed that these mitotic checkpoint proteins are essen-
tial for cell proliferation, causing mice to die during the early 
Figure 1.  Generation of mice with graded 
reduction in Bub1 dosage. (A) Schematic repre-
sentation of the primary Bub1 gene–targeting 
strategy. Part of the Bub1 locus (+), the ﬁ  rst 
targeting vector with loxP sites (gray triangles), 
the Neo hypomorphic allele, the knockout al-
lele generated by the expression of Cre recom-
binase (–), BamHI (B) restriction sites, and the 
Southern probe are indicated. (B) Schematic 
representation of the second Bub1 gene–
targeting strategy. The second targeting vector, 
the Hyg hypomorphic allele, and the BamHI (B) 
and XhoI (X) restriction sites for Southern blot-
ting are indicated. (C) Southern blot analysis 
of mice with the indicated Bub1 genotypes. 
The 21-kb, 9.8-kb, 8.4-kb, and 9.5-kb fragments 
represent the wild-type, Neo hypomorphic, 
knockout, and Hyg hypomorphic alleles, re-
spectively. (D) Western blot analysis of MEFs 
isolated from mice carrying the indicated Bub1 
alleles with a Bub1-speciﬁ  c antibody (actin 
was used as a loading control). The – and H 
alleles can produce truncated protein products 
of 267 amino acids and 318 amino acids, 
respectively. However, we were unable to detect 
these truncated products with our polyclonal 
antibody against Bub1(25–165) (Fig. S1, avail-
able at http://www.jcb.org/cgi/content/full/
jcb.200706015/DC1), sugesting that the pro-
ducts are rapidly degraded and/or that their 
messengers are unstable. (E) Quantitation of 
the level of Bub1 reduction in Bub1
–/H MEFs as 
compared with Bub1
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stages of embryonic development (Dobles et al., 2000; Kalitsis 
et al., 2000; Babu et al., 2003; Baker et al., 2004; Wang et al., 
2004; Iwanaga et al., 2007). Anticipating that Bub1-null mice 
would be embryonically lethal as well, we generated a series of 
mice in which the expression of Bub1 protein is reduced in a 
graded fashion from normal to zero. We fi  nd that Bub1-null 
mice are indeed embryonically lethal but that mice with very 
low levels of Bub1 protein are viable. Here, we show that Bub1 
defi  ciency is associated with aneuploidy and spontaneous tumori-
genesis in a dose-dependent fashion. Furthermore, we provide 
evidence for a novel role of Bub1 in eliminating cells that have 
undergone chromosome missegregation.
Results
Generation of mutant mice with graded 
reduction in Bub1 levels
By homologous recombination, we inserted a neomycin-
resistance (Neo) gene fl  anked by a loxP site into intron 8 and a 
loxP site into intron 9 of the mouse Bub1 gene (Fig. 1 A). This 
created a hypomorphic allele (called Bub1
N) because the Neo 
gene harbors a cryptic exon that is known to reduce the level of 
normally spliced messenger RNA (Jacks et al., 1994; Meyers 
et al., 1998; Baker et al., 2004). Correctly targeted ES clones 
were injected into blastocysts, and Bub1
+/N offspring were ob-
tained from the resulting chimeras (Fig. 1 C). Bub1
+/– mice 
were established by crossing Bub1
+/N males with transgenic 
females that express Cre recombinase in the germline (Fig. 1 C). 
Both Bub1
+/N and Bub1
+/– mice were healthy and indistin-
guishable from wild-type littermates. Subsequent intercrosses 
of Bub1
+/– mice produced no Bub1
–/– newborn mice. Further 
analysis revealed that Bub1
–/– embryos died between days 4.5 
and 6.5 of development (unpublished data), which is in agree-
ment with other mitotic checkpoint gene knockout mice. Also, 
no Bub1
N/N pups were born from intercrosses of Bub1
+/N mice, 
implying that the level of wild-type Bub1 protein produced 
by these hypomorphic alleles was not suffi  cient for successful 
embryonic development.
To bypass this problem, we created a Bub1 hypomorphic 
allele by the use of an alternative method. This method takes 
advantage of a hygromycin B phosphotransferase expression 
(Hyg) cassette that causes a high incidence of premature tran-
scriptional termination when inserted into intronic sequences 
(van Deursen et al., 1994). We constructed a targeting vector to 
introduce this Hyg cassette into intron 9 of the endogenous 
Bub1 gene (Fig. 1 B). Properly targeted ES clones were used to 
produce Bub1
+/H mice. Intercrosses of Bub1
+/H mice yielded 
viable Bub1
H/H offspring at the expected Mendelian frequency. 
Furthermore, interbreeding of Bub1
+/H and Bub1
+/– mice 
yielded viable Bub1
–/H offspring with normal Mendelian fre-
quency (Fig. 1 C). Like Bub1
+/– mice, Bub1
H/H and Bub1
–/H mice 
exhibited no changes in development or appearance when com-
pared with wild-type mice. We performed Western blotting to mea-
sure the level of wild-type Bub1 protein in mouse embryonic 
fi  broblasts (MEFs) derived from Bub1
+/+, Bub1
+/H, Bub1
+/–, 
Bub1
H/H, and Bub1
–/H mice (Fig. 1, D and E). We assessed that 
Bub1 signals from Bub1
+/H, Bub1
+/–, Bub1
H/H, and Bub1
–/H MEFs 
were  75%, 50%, 30%, and 20% of those from Bub1
+/+ MEFs, 
Table I. Inverse correlation between Bub1 expression and aneuploidy in mouse splenocytes
Mouse 
genotype
Age 
(n)
Mitotic 
ﬁ  gures 
inspected
Aneuploid 
ﬁ  gures 
(SD)
Karyotypes with indicated 
chromosome number
Mitotic ﬁ  gures with 
PMSCS (SD)
37 38 39 40 41 42 43 44
mo % %
Bub1
+/+ 5 (3) 150 1 (1) 1 149 0 (0)
Bub1
+/H 5 (5) 250 6 (1) 2 6 236 4 2 2 (1)
Bub1
+/− 5 (3) 150 16 (2) 1 4 6 126 7 6 14 (2)
Bub1
H/H 5 (3) 150 35 (2) 3 8 9 97 16 12 5 4 (1)
Bub1
−/H 5 (3) 150 39 (2) 1 8 15 91 12 15 7 1 15 (2)
Empty spaces mean that there were no karyotypes with the indicated chromosome number.
Table II. Gradual reduction in Bub1 causes progressively more aneuploidy in MEFs
Mitotic MEF 
genotype (n)
Mitotic ﬁ  gures 
inspected
Aneuploid 
ﬁ  gures (SD)
SD Karyotypes with indicated chromosome number Mitotic ﬁ  gures 
with PMSCS 
(SD)
37 38 39 40 41 42 43 44 45 46 80
% %
Bub1
+/+ (3)  150 7 (1) 1 2 3 132 3 2 8 2 (1)
Bub1
+/H (3) 150 11 (1) 1 5 123 6 6 10 2 (1)
Bub1
+/− (3) 150 14 (0) 0 3 8 120 10 9 3 (0)
Bub1
H/H (3) 150 35 (1) 1 4 10 88 21 10 8 9 2 (1)
Bub1
−/H (3) 150 36 (5) 5 3 4 7 83 16 7 9 5 3 2 11 3 (0)
Empty spaces mean that there were no karyotypes with the indicated chromosome number. Karyotyping was performed at passage 5.JCB • VOLUME 179 • NUMBER 2 • 2007  258
Figure 2.  Proper targeting of Mad1 to kinetochores is highly sensitive to Bub1 down-regulation. MEFs with various levels of Bub1 expression were ana-
lyzed for the proper localization of proteins whose association with kinetochores or centromeres is known to be Bub1 dependent. (A) Fluorescent images 
of Bub1
+/+, Bub1
+/–, and Bub1
–/H prophase cells stained for kinetochores, Bub1, and DNA showing that the gradual reduction of cellular Bub1 protein levels 
corresponds with a gradual decline in kinetochore-associated Bub1 protein. (B) Images of Bub1
+/+, Bub1
+/–, and Bub1
–/H prometaphase cells stained for 
kinetochores, Mad1, and DNA demonstrating that kinetochore targeting of Mad1 is highly sensitive to Bub1 down-regulation. (C) Fluorescent images 
of prometaphase cells of the indicated genotypes stained for kinetochores, BubR1, and DNA showing that BubR1 localization to kinetochores is severely 
perturbed in Bub1
–/H MEFs but not in Bub1
+/– MEFs. (D) Fluorescent images of prometaphase cells of the indicated genotypes stained for kinetochores, 
CENP-E, and DNA demonstrating that CENP-E localization to kinetochores is impaired in Bub1
–/H MEFs but not in Bub1
+/– MEFs. (E) Fluorescent images of BUB1 INSUFFICIENCY CAUSES ANEUPLOIDY AND CANCER • JEGANATHAN ET AL. 259
respectively. Truncated forms of Bub1 encoded by the – and H 
alleles were undetectable even after overexposure of the Western 
blots (Fig. S1, available at http://www.jcb.org/cgi/content/full/
jcb.200706015/DC1). Together, these results demonstrated that 
we had produced a series of mice with decreasing Bub1 pro-
tein dosage.
Mice with low amounts of Bub1 have a high 
percentage of aneuploid cells
To determine whether the reduced expression of Bub1 protein 
affects the accuracy of chromosome segregation, we collected 
splenocytes from Bub1
+/+, Bub1
+/H, Bub1
+/–, Bub1
H/H, and 
Bub1
–/H mice at 5 mo of age and prepared metaphase spreads 
for karyotype analyses. Chromosome counts showed that <1% 
of wild-type splenocytes were aneuploid (Table I). In contrast, 
splenocytes from Bub1
+/H, Bub1
+/–, Bub1
H/H, and Bub1
–/H mice 
had a 6%, 16%, 35%, and 39% incidence of aneuploidy, respec-
tively, revealing an inverse correlation between the level of 
Bub1 protein and the percentage of aneuploidy in this cell type. 
Moreover, the range of abnormal chromosome numbers broad-
ened with the decreasing expression of Bub1 protein (Table I). 
We observed the premature separation of sister chromatids 
(PMSCS) in 14 and 15% of the mitotic fi  gures from Bub1
+/– and 
Bub1
–/H splenocytes but only in 4% of the mitotic fi  gures from 
Bub1
H/H splenocytes (Table I). Thus, there seems to be no clear 
link between PMSCS and Bub1 dosage in splenocytes.
We further investigated the effect of Bub1 insuffi  ciency on 
chromosome number stability by performing chromosome counts 
on metaphase spreads from Bub1
+/+, Bub1
+/H, Bub1
+/–, Bub1
H/H, 
and Bub1
–/H MEFs at passage 5. We found that the percentage of 
aneuploid metaphases was much higher in Bub1
H/H and Bub1
–/H 
MEFs than in Bub1
+/– and Bub1
+/H MEFs, which, in turn, had 
a higher percentage than Bub1
+/+ MEFs (Table II). PMSCS was 
not increased in Bub1
+/H, Bub1
+/–, Bub1
H/H, and Bub1
–/H MEFs 
compared with Bub1
+/+ MEFs (Table II). These data confi  rm 
that a high percentage of cells with low levels of Bub1 become 
aneuploid without the apparent requirement of PMSCS.
Kinetochore-associated proteins require 
distinct Bub1 levels for proper localization
Many of Bub1’s critical functions during mitosis occur at the 
kinetochore. Therefore, we tested whether the graded reduction 
of Bub1 expression corresponds to a graded reduction in Bub1 
levels at kinetochores. Immunostaining of Bub1
+/+, Bub1
+/–, 
and Bub1
–/H MEFs with affi  nity-purifi  ed Bub1-specifi  c antibody 
showed that fl  uorescence signals at kinetochores pro  gressively 
declined with decreasing cellular levels of Bub1 expression 
(Fig. 2 A). To examine how this graded reduction in kinetochore-
bound Bub1 affected the localization of mitotic checkpoint pro-
teins whose targeting to kinetochores is Bub1 dependent, we 
immunostained Bub1
+/+, Bub1
+/–, and Bub1
–/H MEFs with 
antibodies against the mitotic checkpoint proteins Mad1, Mad2, 
BubR1, and CENP-E. In Bub1
+/+ prometaphase cells, Mad1 
staining was concentrated on kinetochores visualized by anti-
kinetochore antibody (Fig. 2 B). However, kinetochore-associated 
Mad1 signals were much less abundant in the corresponding 
Bub1
+/– and Bub1
–/H cells. As Mad1 is required for the kineto-
chore localization of Mad2 (Chen et al., 1998, 1999), we antici-
pated that Mad2 staining patterns would also be reduced in 
Bub1
+/– and Bub1
–/H prometaphase cells. We tested this pre-
diction, but despite numerous attempts, we were unsuccessful 
in obtaining kinetochore-associated Mad2 signals in Bub1
+/+ 
MEFs with antibodies that are known to detect Mad2 at kineto-
chores of human prometaphase cells (see Materials and methods 
for details). Unlike Mad1, kinetochore-associated BubR1 and 
CENP-E signals were unaffected in Bub1
+/– cells during pro-
metaphase (Fig. 2, C and D). However, kinetochore signals 
for both of these proteins were dramatically reduced in pro-
metaphase Bub1
–/H cells. Western blot analysis showed that 
Mad1, BubR1, and CENP-E protein levels were similar in Bub1
+/+ 
and Bub1
–/H cells (Fig. S2 A, available at http://www.jcb.org/
cgi/content/full/jcb.200706015/DC1), excluding the possibility 
that the reduction in kinetochore localization of these proteins 
in Bub1
–/H cells is caused by reduced protein stability.
Next, we tested how the graded reduction in kinetochore-
bound Bub1 levels affected the subcellular localization of Sgo1 
and Aurora B, both of which have been reported to require Bub1 
for their proper localization to the centromeres (Tang et al., 
2004b, 2006; Kitajima et al., 2005; Boyarchuk et al., 2007). 
Fewer Sgo1-positive centromeres were observed in Bub1
–/H 
prometaphases than in Bub1
+/+ prometaphases (Fig. 2 E). 
In contrast, no such decrease was observed in Bub1
+/– prometa-
phase cells (unpublished data). Immunostainings for Aurora B 
revealed that the localization of this protein was normal in both 
Bub1
+/– and Bub1
–/H prometaphase cells (Fig. S2 B). Thus, 
whereas most proteins that require Bub1 for proper localization 
to kinetochores/centromeres are mislocalized in Bub1
–/H MEFs, 
only Mad1 is mislocalized in Bub1
+/– cells.
Bub1 insufﬁ  cient cells have a weakened 
mitotic checkpoint
To analyze the activity of the mitotic checkpoint in MEFs with a 
graded reduction in Bub1 expression, we performed a nocodazole 
challenge assay (Jeganathan et al., 2005; Baker et al., 2006). 
In this assay, MEFs were fi   rst transduced with a retro  virus 
encoding a YFP-tagged H2B fusion protein to allow the visual-
ization of chromosomes by fl  uorescence microscopy (Fig. 3 A). 
MEFs were then challenged with nocodazole, and 20–30 cells 
undergoing nuclear envelope breakdown (NEBD) were marked 
and monitored at 15-min intervals to determine when their 
chromatin decondenses. The duration of arrest in mitosis, which 
is defi  ned as the interval between NEBD (onset of mitosis) and 
chromatin decondensation (exit from mitosis without cytokinesis), 
was calculated and plotted. The time at which 50% of the cells 
have exited mitosis was used for comparison. Nocodazole-
challenged Bub1
+/+ MEFs typically remained arrested in 
Bub1
+/+ and Bub1
–/H prometaphase cells stained for kinetochores and Sgo1 showing that considerably fewer Sgo1-positive centromeres are present in 
Bub1
–/H MEFs. Bar, 10 μM.JCB • VOLUME 179 • NUMBER 2 • 2007  260
prometaphase for 7.2 h (Fig. 3 B). Bub1
+/H and Bub1
+/– MEFs 
were impaired in their ability to maintain this arrest, with 50% 
of the cells exiting around 5.4 h. However, Bub1
H/H and Bub1
–/H 
MEFs exhibited a more profound defect, with 50% of the cells 
exiting mitosis at 3.8 h and 3.5 h, respectively. Thus, the mi-
totic checkpoint appears to be considerably weaker in Bub1
H/H 
and Bub1
–/H MEFs than in Bub1
+/H and Bub1
+/– MEFs.
Bub1 insufﬁ  ciency causes various 
chromosome segregation defects
Next, MEFs with graded reductions in Bub1 expression were 
screened for chromosome segregation defects. In essence, we 
followed YFP-H2B–positive MEFs through an unchallenged 
mitosis by live cell imaging and determined the fraction of 
mitotic cells with chromosome segregation abnormalities. 
Two known defects underlying chromosome missegregation, 
congression failure and chromosome lagging (Fig. 4, A and B), 
were observed at higher rates in Bub1
+/H, Bub1
+/–, Bub1
H/H, 
and Bub1
–/H MEFs than in Bub1
+/+ MEFs (Table III). The com-
bined incidence of the aforementioned defects was remark-
ably similar in Bub1
+/H, Bub1
+/–, Bub1
H/H, and Bub1
–/H MEFs 
(Table III). Furthermore, anaphases with centrophilic chromo-
somes that segregate faster than the other chromosomes (Fig. 4 C) 
were observed at an approximately two- to fi  vefold higher 
frequency in Bub1
+/H, Bub1
+/–, Bub1
H/H, and Bub1
–/H MEFs 
than in Bub1
+/+ MEFs (Table III). Whether this type of ab-
normality leads to chromosome missegregation is unclear, but 
even with the inclusion of this defect, the overall incidence of 
chromosome segregation abnormalities remains very similar 
in Bub1
+/H, Bub1
+/–, Bub1
H/H, and Bub1
–/H MEFs (Table III). 
Irrespective of Bub1 genotype, most cells with abnormal chromo-
some segregation events involved a single chromosome (or a 
duplicated chromosome). Occasionally, two or three chromo-
somes were implicated (Table IV and Table S1, available at 
http://www.jcb.org/cgi/content/full/jcb.200706015/DC1). Thus, 
the aforementioned analyses suggest that the accuracy of 
Figure 3.  Mitotic checkpoint activity analysis. (A) Schematic 
of the experimental design (for details see the ﬁ  rst two para-
graphs of Results). (B) Analysis of mitotic checkpoint activity of 
MEFs of the indicated genotypes (n = 3 for each genotype). 
Error bars represent the SEM. Dotted arrows mark the times at 
which 50% of cells had exited from mitosis. Asterisks indicate 
a statistical difference from Bub1
+/+, Bub1
+/H, and Bub1
+/– 
MEFs using the logrank test (*, P < 0.001).
Figure 4.  Bub1 insufﬁ  ciency causes various chromosome segregation errors. (A) Examples of metaphases with misaligned chromosomes (arrows). (B) Ana-
phases with lagging chromosomes (arrows). (C) Anaphase with a centrophilic chromosome (arrow).BUB1 INSUFFICIENCY CAUSES ANEUPLOIDY AND CANCER • JEGANATHAN ET AL. 261
chromosome segregation is highly dependent on a full comple-
ment of Bub1 protein and that both small and large reductions 
in Bub1 cause chromosome missegregation at comparable rates.
Reduced cell death after chromosome 
missegregation as Bub1 levels decline
Initially, we were surprised that chromosome missegregation 
rates were similar in Bub1
+/H, Bub1
+/−, Bub1
H/H, and Bub1
−/H 
MEFs because the percentage of aneuploid cells was much 
higher in Bub1
H/H and Bub1
−/H cultures than in Bub1
+/H and 
Bub1
+/− cultures (Table II). One explanation could be that cell 
survival after chromosome missegregation increases with de-
creasing Bub1 levels. To explore this possibility, we infected 
Bub1
+/+, Bub1
+/H, Bub1
+/–, Bub1
H/H, and Bub1
–/H MEFs with 
the YFP-H2B virus and monitored the fate of cells undergoing 
chromosome missegregation for up to 12 h by live cell imaging. 
Typically, 95% of Bub1
+/+ MEFs died within several hours after 
chromosome missegregation (Table V and Videos 5 and 6, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200706015/DC1). 
This percentage declined progressively and sharply as Bub1 ex-
pression decreased, with only 32% of Bub1
–/H MEFs dying after 
a missegregation event (Table V, Fig. 5 A, and Videos 1 and 2). 
Cells dying after chromosome missegregation consistently showed 
nuclear fragmentation and/or cytoplasmic blebbing (Fig. 5, 
B and C; and Videos 3, 4, 7, and 8). Cells with accurate segrega-
tion rarely died during the 12-h observation period, irrespective 
of Bub1 genotype (Table V and Videos 9 and 10). From this, 
we conclude that although the rates of chromosome missegrega-
tion are comparable at various levels of Bub1 reduction, aneu-
ploid cells accumulate to higher steady-state levels in cultures 
with low amounts of the protein because cells in these cultures 
are more likely to survive after chromosome missegregation. 
Consistent with this interpretation, we found that micronuclei, 
which we observed by live cell imaging to result from misaligned, 
centrophilic, or lagging chromosomes, accumulated steadily with 
decreasing Bub1 levels (Fig. S3).
To explore whether Bub1 plays a more general role in cell 
death signaling, we measured cell survival to various kinds of 
DNA-damaging agents. MEFs with graded reduction in Bub1 
protein levels were exposed to increasing concentrations of 
doxorubicin, mitomycin C, or paraquat for 48 h. Cell survival 
was then determined by using the MTS assay. Cell survival in 
these agents was similar for Bub1
+/+, Bub1
+/H, Bub1
+/–, Bub1
H/H, 
and Bub1
–/H MEFs (Fig. S4, A–C; available at http://www.jcb
.org/cgi/content/full/jcb.200706015/DC1). In addition, decreased 
Bub1 expression also did not increase survival to prolonged 
exposure to nocodazole, a spindle poison that induces tetra-
ploidization by driving prometaphase cells into G1 without 
chromosome segregation (Fig. S4 D). These experiments sug-
gest a rather specifi  c role for Bub1 in mediating cell death after 
the missegregation of one or a few chromosomes.
Spontaneous tumorigenesis is increased 
in Bub1 hypomorphic mice
To determine the long-term consequences of Bub1 down-
regulation, we created and monitored cohorts of Bub1
+/+ (n = 
160), Bub1
+/– (n = 142), Bub1
H/H (n = 137), and Bub1
–/H 
(n = 238) mice on a mixed 129 × C57BL/6 background. Earlier, 
we reported that BubR1 hypomorphic mice have a short lifespan, 
are infertile, and develop various early aging–associated pheno-
types (Baker et al., 2004). We note that no such phenotypes 
were observed in any of our Bub1 mutant mice (unpublished 
data). However, we found that Bub1
–/H and Bub1
H/H mice were 
signifi  cantly more prone to spontaneous tumors than Bub1
+/+ 
Table III. Analysis of chromosome segregation abnormalities in Bub1-insufﬁ  cient MEFs
MEF genotype (n) Mitotic cells 
inspected
Metaphases with 
misaligned 
chromosomes
Anaphases with 
lagging 
chromosomes
Anaphases with 
centrophilic 
chromosomes
Cells with 
segregation defects
a
%% %%
Bub1
+/+ (5) 106 0.9 3.8 0.9 4.7 (5.6)
Bub1
+/H (4) 91 3.3 6.6 3.3 9.9 (13.2)
Bub1
+/− (6) 142 7.7 6.3 2.1 12 (14.1)
Bub1
H/H (4) 122 6.5 4.9 4.8 11.6 (16.4)
Bub1
−/H (5) 168 7.1 6.6 2.4 13.1 (15.5)
All cells scored as metaphases with misaligned chromosomes displayed congression failure at anaphase onset.
aPercentage of cells with misaligned and/or lagging chromosomes. The percentage of cells with chromosome segregation abnormalities is presented in parentheses.
Table IV. Most chromosome missegregation events involve a single chromosome irrespective of the level of Bub1 expression
Mitotic ﬁ  gures 
inspected (n)
Number of cells with 
segregation defects
a
Number of cells with one abnormally 
segregated chromosome
Number of cells with two or 
three abnormally segregated 
chromosomes
b
Bub1
+/+ (106) 6 6 (100%) 0 (0%)
Bub1
+/H (91) 12 11 (92%) 1 (8%)
Bub1
+/– (142) 20 15 (75%) 5 (25%)
Bub1
H/H (122) 20 17 (85%) 3 (15%)
Bub1
–/H (168) 26 21 (81%) 5 (19%)
aThe chromosomes involved were either single chromosomes or duplicated chromosomes.
bNone of the cells had more than three abnormally segregated chromosomes (see Table S1).JCB • VOLUME 179 • NUMBER 2 • 2007  262
mice (Fig. 6, A and B). Bub1
–/H mice had a signifi  cantly shorter 
median tumor-free survival (530 d) than Bub1
H/H mice (676 d), 
which, in turn, had a signifi  cantly shorter median tumor-free 
survival than Bub1
+/+ mice (772 d; Fig. 6 B). Moreover, Bub1
–/H 
and Bub1
H/H mice developed a different spectrum of tumors 
than did Bub1
+/+ mice (Fig. 6, C–F′). Bub1
–/H mice developed 
signifi  cantly more sarcomas, lymphomas, and lung tumors. 
Bub1
H/H mice were also prone to develop sarcomas but not lym-
phomas and lung tumors. Bub1
H/H mice were highly susceptible 
to hepatocellular carcinomas, a tumor type that was not signifi  -
cantly increased in Bub1
–/H mice. In contrast to Bub1
–/H and 
Bub1
H/H mice, Bub1
+/– mice showed a trend toward decreased 
tumor formation, particularly in liver and lung tissue (Fig. 6, 
B and C). Collectively, these data establish a causal relationship 
between the down-regulation of Bub1 expression and cancer 
development and suggest that there is a threshold level of Bub1 
below which the incidence of neoplastic transformation pro-
gressively increases. Our data further imply that Bub1 reduc-
tions above the threshold may slightly inhibit tumor formation 
in particular tissues.
Increased incidence of DMBA-induced 
tumors in Bub1 mutant mice
Based on the aforementioned data, we conclude that Bub1
+/– 
mice have enough Bub1 protein to protect themselves against 
spontaneous tumorigenesis. To determine whether this level is 
suffi  cient to guard against carcinogen-induced tumors, we ad-
ministered a single dose of 0.5% DMBA (9,10-dimethylbenz-A-
athracene) in acetone to the dorsal skin of 3–5-d-old pups 
generated from Bub1
+/– × Bub1
+/+ intercrosses. 5 mo after 
Figure 5.  Analysis of cell fate after chromosome missegregation by live cell imaging. MEF cultures expressing YFP-tagged H2B were screened for cells 
entering mitosis by live cell imaging. Cells undergoing chromosome missegregation were monitored for up to 12 h after the missegregation occurred to deter-
mine cell fate. (A) Time-lapse sequence of a Bub1
–/H cell undergoing chromosome missegregation and whose daughter cells survived for at least 12 h. 
t = 0 is the time at which missegregation occurred. (B) Time-lapse sequence of a Bub1
+/– cell undergoing chromosome missegregation whose daughter 
cells died  7 h after the defect occurred. (A and B) Arrows mark the locations of the missegregated chromosomes. (C) High resolution images of two 
Bub1
+/– daughter cells undergoing cell death  5 h after they underwent chromosome missegregation. 
Table V. Cell death after chromosome missegregation decreases as Bub1 expression declines
MEF genotype (n) Cells with missegregation 
monitored
a
Apoptosis 
incidence
Apoptosis 
(1 cell)
Apoptosis 
(2 cells)
Cells with normal 
mitosis monitored
Apoptosis 
incidence
%% % %
Bub1
+/+ (3) 16 94 0 100 38 3
Bub1
+/H (3) 28 68 26 74 17 6
Bub1
+/– (3) 23 65 9 91 7 0
Bub1
H/H (3) 26 42 12 88 16 0
Bub1
–/H (3) 31 32 14 86 14 0
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treatment, we killed the mice and screened for tumors. Irrespec-
tive of the genotype, tumors were exclusively detectable in 
the lungs. Bub1
+/– mice exhibited a two- to threefold higher 
incidence of lung tumors than in Bub1
+/+ mice (Fig. 7 A). 
Moreover, the tumor burden of Bub1
+/– mice was increased 
approximately threefold (Fig. 7 B). From this experiment, we 
conclude that Bub1 heterozygous knockout mice are prone to 
carcinogen-induced tumorigenesis.
Discussion
In this study, we produced a series of mutant mice in which the 
expression of Bub1 is reduced in a graded fashion from normal 
to zero by the use of wild-type, hypomorphic, and knockout 
alleles to determine the physiological role of Bub1. As anticipated, 
we fi  nd that the complete loss of Bub1 leads to embryonic 
lethality. Strongly reduced Bub1 expression (up to approximately 
Figure 6.  Bub1
–/H and Bub1
H/H mice are 
prone to spontaneous tumors. (A) Tumor-free 
survival curves of Bub1
+/+, Bub1
+/–, Bub1
H/H, 
and Bub1
–/H mice. The asterisks mark curves 
that are signiﬁ   cantly different from wild-type 
using a logrank test (P < 0.0001). We note 
that the tumor-free survival of a small cohort of 
Bub1
+/H mice (n = 10) was similar to that of 
Bub1
+/+ mice (not depicted). Furthermore, the 
median tumor-free survival of Bub1
–/H mice 
was signiﬁ  cantly shorter than that of Bub1
H/H 
mice (P < 0.01). (B) Spontaneous tumor inci-
dence and tumor latency of Bub1
+/+, Bub1
+/–, 
Bub1
H/H, and Bub1
–/H mice. (C) Tumor spectrum 
of Bub1
+/+, Bub1
+/–, Bub1
H/H, and Bub1
–/H 
mice. Asterisks mark values that are signiﬁ  cantly 
different from wild type using a Fisher exact 
Chi-square test. (D) An overt hepato  cellular carci-
noma is indicated by the dashed line. (D′) Hema-
toxylin and eosin stained well-differentiated 
hepatocellular carcinoma, showing a prolifera-
tion of mildly atypical hepatocytes with abundant 
vascular channels, a lack of normal portal tracts, 
and a nodular focus (arrowheads) with mildly 
thickened trabeculae. (E) Thymic lymphoma 
(dashed line). (F) Overt lung adenocarcinoma 
(dashed circle). (F′) Hematoxylin and eosin–
stained low-power magniﬁ  cation of a typical 
lung adenocarcinoma (dashed circle).JCB • VOLUME 179 • NUMBER 2 • 2007  264
fi  vefold reduction) does not interfere with embryogenesis and 
allows for the development of adult mice that are overtly in-
distinguishable from their wild-type littermates. However, the 
reduction of Bub1 levels does have adverse consequences on 
genomic stability in these cells. Karyotyping of splenocytes and 
MEFs from our series of mutant mice established an inverse cor-
relation between Bub1 expression level and aneuploidy. Failure of 
chromosome congression during metaphase is the main chromo-
some segregation defect resulting from Bub1 insuffi  ciency. 
Although small and large reductions in Bub1 levels cause simi-
lar rates of chromosome missegregation, rates of cell survival 
after aberrant chromosome segregation increase considerably 
with declining Bub1 levels, providing a plausible explanation 
for why large reductions cause more aneuploidy than small ones. 
Furthermore, the reduction of Bub1 protein affected the strength 
of the mitotic checkpoint and loading of certain proteins onto 
centromeres or kinetochores. Bub1 haploinsuffi  ciency in mice does 
not cause spontaneous tumors, but, as Bub1 levels drop further, 
animals become highly susceptible to a variety of spontaneous 
tumors, with the highest rate of tumorigenesis seen at the lowest 
level of Bub1 expression.
Bub1 is known to be required for the binding of several 
other mitotic checkpoint proteins to kinetochores (Sharp-Baker 
and Chen, 2001; Johnson et al., 2004; Meraldi et al., 2004). 
Our analysis of MEFs with graded reduction in Bub1 expression 
now reveals that these proteins require different levels of Bub1 
protein for their normal recruitment to kinetochores. In particu-
lar, the recruitment of Mad1 to kinetochores is dramatically 
reduced when Bub1 is down-regulated. We speculate that Mad2, 
which forms a complex with Mad1 at kinetochores (Yu, 2006), 
is similarly sensitive to Bub1 down-regulation, although we 
were unable to confi  rm this because of the lack of an antibody 
that detects mouse Mad2 at kinetochores. Besides Mad1, the re-
cruitment of BubR1 and CENP-E to kinetochores is also sensi-
tive to Bub1 down-regulation, but not as sensitive as Mad1, 
as their localization is normal in Bub1 heterozygous MEFs. 
Recent studies have presented evidence that Bub1 functions to 
recruit Sgo1 to centromeres to prevent the precocious separation 
of sister kinetochores (Tang et al., 2004b; Kitajima et al., 2005). 
Consistent with these studies, we fi  nd that centromeric Sgo1 
levels are reduced in Bub1 mutant MEFs, but only when Bub1 
expression is strongly down-regulated. However, this did not 
result in premature sister kinetochore separation, implying that 
an even further drop in centromeric Sgo1 is required to trigger 
the cleavage of cohesin molecules that link sister centromeres. 
A recent study has implicated Bub1 in the targeting of chromo-
somal passenger complexes to centromeres in early mitosis 
(Boyarchuk et al., 2007). Our fi  nding that very low amounts of 
Bub1 are suffi  cient for directing these complexes to centromeres 
suggests that near complete Bub1 depletion is required to dis-
locate the passenger complex from mitotic centromeres.
One of our more surprising fi  ndings is the observation that 
a relatively small reduction in Bub1 expression has a major 
  impact on the accuracy of chromosome congression. What could 
be the explanation for this observation? Although the precise 
role of Bub1 in chromosome congression is currently not known, 
it is believed that this role involves kinetochore assembly 
(Meraldi and Sorger, 2005). Of the mitotic checkpoint proteins 
whose recruitment is Bub1 dependent, only CENP-E has so 
far been implicated in chromosome congression. Thus, one 
explanation for the congression failure in Bub1 mutant MEFs 
might be a CENP-E recruitment defect. Consistent with this, we 
fi  nd that the targeting of CENP-E to kinetochores is perturbed 
in Bub1 hypomorphic MEFs. On the other hand, Bub1 haplo-
insuffi  cient MEFs, which display similar rates of congression 
failure as Bub1 hypomorphic MEFs, exhibit normal CENP-E 
recruitment to kinetochores, implying that the mechanism of 
congression failure is CENP-E independent. This conclusion is 
further supported by data of Meraldi and Sorger (2005) demon-
strating that the depletion of Bub1 in HeLa cells by RNA inter-
ference causes chromosome congression defects in the absence 
of CENP-E mislocalization. Therefore, it remains unclear how 
Bub1 promotes proper chromosome congression. Nonetheless, 
we suspect that it involves a known or novel kinetochore-
associated protein that functions in microtubule capture and 
whose recruitment to kinetochores is highly dependent on a full 
complement of Bub1.
Our analysis of MEFs with graded reduction in Bub1 ex-
pression indicates that relatively small shortages in Bub1, such 
as those seen in Bub1
+/H and Bub1
+/– MEFs, weaken the mitotic 
checkpoint considerably. It is plausible that the impaired recruit-
ment of Mad1 (and presumably Mad2) to kinetochores undermines 
the mitotic checkpoint in these cells, as kinetochore-associated 
Mad1–Mad2 complexes generate soluble Mad2–Cdc20 com-
plexes that bind to and inactivate APC/C. Larger reductions in 
Bub1, as present in Bub1
H/H and Bub1
–/H MEFs, had an even 
Figure 7.  DMBA-induced tumor formation in Bub1 haploinsufﬁ  cient mice. 
(A) The occurrence of lung tumors in 5-mo-old mice plotted as the percent-
age of incidence. (B) The mean number of lung adenomas per mouse ± 
SEM (error bars). (A and B) The asterisk marks a value that is signiﬁ  cantly 
different from wild type using a chi-squared test (A) and a Wilcoxon rank 
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more profound impact on mitotic checkpoint activity. We pro-
pose that this is caused, at least in part, by the added loss of 
CENP-E and BubR1 from kinetochores, as kinetochore-bound 
CENP-E and BubR1 molecules have been implicated in the as-
sembly of various inhibitory protein complexes that target APC/C 
(Mao et al., 2003, 2005). The Bub1 kinase also can inhibit 
APC/C directly through the phosphorylation of Cdc20 (Chung 
and Chen, 2003; Chen, 2004; Tang et al., 2004a). We have not 
addressed whether the phosphorylation of Cdc20 is affected in 
our mutant series of MEFs as a result of the current lack of anti-
bodies that recognize phosphorylated mouse Cdc20.
Although it has been well established that gross ab-
normalities of chromosome segregation (frequently referred to 
as mitotic catastrophe) often cause cell death (Castedo et al., 
2004), the fate of cells undergoing the random missegregation 
of only one or a few chromosomes has been unknown. Here, we 
show by the use of live cell imaging that wild-type primary MEFs 
die at very high rates after minor abnormalities in chromosome 
segregation. The implication of this fi  nding is that aneuploidy 
rates in cultured wild-type MEFs are substantially higher than 
metaphase spread karyotypes reveal. Our discovery that cell 
death rates after chromosome missegregation dramatically 
decline with decreasing levels of Bub1 creates a molecular 
entry point for studying the underlying cell death mechanism. 
Whether Bub1 plays a unique role in this mechanism or whether 
there is a broader connection between mitotic checkpoint dam-
age and decreased cell death after chromosome missegregation 
is an important question for future analysis. Bub1’s dual func-
tion as a guardian of high fi  delity chromosome segregation and as 
a mediator of cell death after aberrant segregation is reminiscent 
of proteins such as ATM (ataxia telangiectasia mutated) and p53 
that function in both DNA repair and apoptosis in response to 
DNA damage (Sancar et al., 2004). A recent study showed that 
Bub1-depleted cancer cell lines display increased mitotic cell 
death when they are exposed to agents that perturb kinetochore-
microtubule attachment, such as nocodazole (Niikura et al., 2007). 
We observed no such effect in nocodazole-treated MEFs with 
graded reduction in Bub1 expression (Fig. S4 D), suggesting 
that the impact of the Bub1 level of expression on mitotic cell 
death induced by spindle poisons is cell type and/or transforma-
tion status dependent.
Bub1 expression is reduced in several human cancers, 
including colorectal, gastric, and esophageal tumors (Shigeishi 
et al., 2001; Shichiri et al., 2002; Doak et al., 2004); however, it 
was unknown whether the reduced expression of this mitotic 
checkpoint protein is causally implicated in tumorigenesis. 
Analysis of our series of Bub1 mutant mice fi  rmly establishes 
that the reduced expression of Bub1 leads to the development 
of spontaneous tumors in mice, but only when Bub1 levels fall 
below a threshold level. Those with the most drastic reductions of 
Bub1 expression have the shortest tumor latency and the highest 
incidence of tumors. The level of Bub1 required to prevent 
spontaneous tumorigenesis appears to vary per tissue, as illus-
trated by the fact that only mice with the most profound reduc-
tion in Bub1 are predisposed to lymphomas and lung tumors. 
In the liver, the optimal level of Bub1 down-regulation is not the 
lowest level, as Bub1
H/H mice but not Bub1
–/H mice are prone to 
hepatocellular carcinomas. Adding even more complexity is the 
discovery that Bub1 haploinsuffi  ciency exerts a slight tumor-
suppressive effect in both liver and lung tissue. This fi  nding is 
consistent with the recent discovery that CENP-E haploinsuffi  -
ciency inhibits tumorigenesis in certain mouse tissues (Weaver 
et al., 2007). However, unlike CENP-E insuffi  ciency, Bub1 haplo-
insuffi  ciency does not inhibit DMBA-induced tumorigenesis. 
In fact, Bub1 haploinsuffi  cient mice are highly susceptible to 
lung tumors when challenged with this carcinogen. This obser-
vation implies that the loss of one Bub1 gene copy acts to accel-
erate the development of tumors initiated by particular cancer 
gene mutations.
Because Bub1 hypomorphic mice have a high percentage 
of aneuploid cells and are predisposed to spontaneous tumors, 
whereas Bub1 haploinsuffi  cient mice have a relatively low per-
centage of aneuploid cells and are not tumor prone, it is tempt-
ing to speculate that it is the increase in aneuploidy that drives 
tumorigenesis in Bub1 hypomorphic mice. However, the fact 
that both Rae1/Bub3 and Rae1/Nup98 double-haploinsuffi  cient 
mice develop aneuploidy at rates very similar to that of Bub1 
hypomorphic mice but are not prone to spontaneous tumors 
argues against this idea (Babu et al., 2003; Baker et al., 2006; 
Jeganathan et al., 2005, 2006). One possible explanation for this 
discrepancy could be that as a result of the decreased cell death 
in response to chromosome missegregation, Bub1 hypomorphic 
mice may develop a wider variety of abnormal karyotypes than 
Rae1/Bub3 and Rae1/Nup98 double-haploinsuffi  cient  mice, 
thereby perhaps increasing the incidence of karyotypes that 
have the ability to drive tumorigenesis. However, the role of 
aneuploidy in tumorigenesis is clearly highly complex, and it 
will be necessary to carefully examine each individual regulator 
of chromosome segregation for its involvement in tumorigenesis 
through the use of animal models. We expect these efforts to 
allow the identifi  cation of a subset of mitotic regulators that are 
particularly important for tumor prevention. Among them may 
be mitotic regulators that serve as molecular hubs within the 
mitotic checkpoint or other networks that regulate proper chromo-
some segregation or mitotic regulators with connectivity to other 
pathways that guard against neoplastic transformation.
In this study, we have used a series of mutant mice to demon-
strate that only after reducing Bub1 levels beyond a threshold 
level do mice start to develop spontaneous tumors. Had we used 
only Bub1 haploinsuffi  cient mice rather than a series of mice 
with graded reduction in Bub1 expression, our conclusions 
would have been dramatically different in that we would con-
clude that Bub1 does not act as a tumor suppressor itself. 
Heterozygous knockout models for several other mitotic check-
point genes are also not predisposed to spontaneous tumorigenesis. 
For a more defi  nitive understanding of the roles these genes 
have in tumor prevention, it will be useful to use hypomorphic 
alleles to further reduce their level of expression in mice.
Materials and methods
Generation of Bub1 mutant mice and analyses of tumorigenesis
An 8.5-kb Bub1 129Sv/J genomic DNA fragment was used to generate 
both targeting vectors used. Gene-targeting procedures were performed as 
previously described (van Deursen et al., 1996). We identiﬁ  ed targeted ES JCB • VOLUME 179 • NUMBER 2 • 2007  266
cell clones by Southern blot analysis using a 3′ probe on BamHI-cut geno-
mic DNA (Fig. 1 A). Mutant mice were derived from targeted ES cell clones 
through standard procedures. These mice were maintained on a mixed 
129Sv/E × C57BL/6 genetic background. Mice in tumor susceptibility 
experiments were observed daily for the development of overt tumors or 
signs of ill health. Moribund mice were killed, and all major organs were 
screened for overt tumors using a dissection microscope (SZX12; Olympus). 
Tumors that were collected were processed by standard procedures for 
histopathology. Prism software (GraphPad Software, Inc.) was used for the 
generation of tumor-free survival curves and for statistical analyses. DMBA 
treatment was performed as previously described (Serrano et al., 1996; 
Babu et al., 2003). All major organs were screened for overt tumors using 
a dissection microscope (SZX12; Olympus). Harvested tumors were rou-
tinely processed for histopathological conﬁ  rmation. We note that all mice 
were housed in a pathogen-free barrier environment.
Western blot analysis and indirect immunoﬂ  uorescence
Western blot analyses and indirect immunoﬂ  uorescence were performed 
as previously described (Kasper et al., 1999). A laser-scanning micro-
scope (LSM 510 v3.2SP2; Carl Zeiss MicroImaging, Inc.) as well as a 
microscope (Axiovert 100M; Carl Zeiss MicroImaging, Inc.) with a 
c-Apochromat 100× oil immersion objective (Carl Zeiss MicroImaging, Inc.) 
was used to analyze immunostained cells and to capture representative 
images. Primary antibodies were visualized with appropriate secondary 
antibodies conjugated to AlexaFluor594, -488. or -647 (Invitrogen). 
Primary antibodies used for Western blotting and indirect immuno-
ﬂ   uorescence were as follows: rabbit anti–human Bub1(25–165), rabbit 
anti–human BubR1(382–420) (Baker et al., 2004), rabbit anti–human 
Mad1 (provided by T. Yen, Fox Chase Cancer Center, Philadelphia, PA), 
rabbit anti–human SgoI([1–262][177–351]) (provided by H. Yu, Univer-
sity of Texas Southwestern, Houston, TX; Tang et al., 2004b), mouse anti–
Aurora B (BD Biosciences), human anticentromeric antibody (Antibodies, 
Inc.), and rabbit anti–CENP-E (provided by D. Cleveland, Ludwig Institute 
for Cancer Research, La Jolla, CA). Mad2 antibodies tested were as 
follows: rabbit anti–human Mad2(FL-205) (Santa Cruz Biotechnology, Inc.), 
mouse anti–human Mad2 (BD Biosciences), and rabbit anti–human Mad2 
(Covance). None of these Mad2 antibodies detects Mad2 at kinetochores 
of mitotic MEFs.
Karyotyping of MEFs and splenocytes
Chromosome counts on metaphase spreads were performed as previously 
described (Babu et al., 2003). We note that cells were scored as diploid 
(n = 40 chromosomes), tetraploid (n = 80 chromosomes), or aneuploid 
(Weaver et al., 2007).
Live cell imaging experiments
To allow the visualization of chromosomes by ﬂ  uorescent microscopy on 
living cells, we used a retrovirus expressing YFP-tagged H2B (Jeganathan 
et al., 2005). Passage 2 MEFs were seeded in T25 ﬂ  asks at 75% conﬂ  uence 
and cultured in DME/10% FBS at 3% oxygen. 12 h after seeding and again 
every 12 h for at least three times, the medium was replaced with medium 
harvested from EcoPACK pMSCV-puro-H2B-YFP viral producer cell lines. 
Cells were then seeded onto 35-mm glass-bottomed culture dishes (MatTek 
Corp.) and cultured in DME/10% FBS. Approximately 24 h later, experi-
ments were performed using a microscope system (Axio Observer; Carl 
Zeiss MicroImaging, Inc.) with CO2 Module S, TempModule S, Heating Unit 
XL S, a plan Apo 63× NA 1.4 oil differential interference contrast III objec-
tive (Carl Zeiss MicroImaging, Inc.), camera (AxioCam MRm; Carl Zeiss 
MicroImaging, Inc.), and AxioVision 4.6 software (Carl Zeiss MicroImag-
ing, Inc.). The imaging medium was DME/10% FBS. The temperature of the 
imaging medium was kept at 37°C. The exposure times in nocodazole chal-
lenge experiments were 100 ms at 2 × 2 binning. Time of arrest in mitosis 
was deﬁ  ned as the interval between NEBD (onset of mitosis) and chromatin 
decondensation (exit from mitosis without cytokinesis). Interframe intervals 
were 15 min for nocodazole challenge. Analysis of mitotic defects was per-
formed as previously described (Baker et al., 2006). For analysis of the inci-
dence of cell death after chromosome missegregation, MEFs undergoing 
abnormal chromosome segregation were marked and followed with an 
interframe interval of 30 min for up to 12 h. Cell death was preceded by 
severe nuclear blebbing and cytoplasmic fragmentation. For each of the 
aforementioned experiments, we examined at least three independent 
clones per genotype unless otherwise noted. Prism software (GraphPad Soft-
ware, Inc.) was used for statistical analyses. To evaluate the incidence of 
micronuclei formation, at least 600 YFP-H2B–expressing interphase MEFs 
were screened for the presence of micronuclei by live cell microscopy.
Cell survival assays
Analyses of cell survival in response to doxorubicin, mitomycin C, and 
paraquat were performed as described previously (Baker et al., 2004) 
with the exception that passage 3 MEFs were used instead of passage 2 
MEFs. For analysis of cell death in response to nocodazole treatment, 10
5 
passage 3 MEFs were seeded in duplicate for three independent cell lines 
of each genotype. After  12 h, normal medium was replaced with me-
dium containing 100 ng/ml nocodazole, and cells were cultured for an 
additional 72 h. All cells were collected after this time, and tryptan blue 
exclusion was used to count living cells.
Online supplemental material
Fig. S1 shows that truncated proteins encoded by the Bub1 knockout and 
hypomorphic alleles are undetectable by immunoblotting. Fig. S2 shows that 
Mad1, BubR1, and CENP-E protein levels were similar in Bub1
+/+ and Bub1
–/H 
cells and that Aurora B is not mislocalized in Bub1
–/H cells. Fig. S3 shows that 
the incidence of micronuclei increases with declining levels of Bub1. 
Fig. S4 shows that the Bub1 level of expression has no impact on MEF cell 
survival to DNA-damaging agents and prolonged nocodazole exposure. Videos 
1 and 2 show videos of the Bub1
–/H MEF presented in Fig. 5 A. Videos 3 and 4 
show videos of the Bub1
+/– MEF presented in Fig. 5 B. Videos 5 and 6 show 
a Bub1
+/+ MEF undergoing chromosome missegregation in mitosis. Both 
daughter cells die after exit from mitosis. Videos 7 and 8 show a Bub1
+/H 
MEF undergoing chromosome missegregation. One of the two daughter cells 
undergoes cell death. Videos 9 and 10 show a Bub1
H/H MEF undergoing nor-
mal chromosome segregation. Both daughter cells survive. Table S1 presents 
data about the number of chromosomes that are abnormally segregated in 
cells with mutliple segregation defects. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.200706015/DC1.
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